← FDA Drug Approvals (Drugs@FDA)

GRIFULVIN V

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VALEANT LUXEMBOURG · Approved 1984-01-26

Drug application

FDA Application #
ANDA062483
Application type
Abbreviated New Drug Application (Generic)
Brand name
GRIFULVIN V
Generic name
Griseofulvin, Microsize
Active ingredients
GRISEOFULVIN, MICROSIZE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Discontinued
Sponsor
VALEANT LUXEMBOURG
First approval
1984-01-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown